Genotoxic stress such as ionizing radiation (IR) causes DNA damage and thereby induces diverse cellular responses such as cell cycle arrest and the activation of the DNA damage response (DDR) pathways to deal with this threat.^[@bib1]^ These complex DDRs are regulated by the PI3K-like kinases ATM, ATR and DNA-PK, which regulate downstream effectors that induce cell cycle checkpoints via phosphorylation of checkpoint kinases (Chk1/2), phosphatases (Cdc25) as well as stabilization of p53 and activation of the p16INK4a-Rb pathway to delay progression into the S phase or mitosis.^[@bib2]^ Following the detection of DNA breaks, ATM initiates a nuclear signaling cascade, leading to the phosphorylation of protein substrates such as histone H2A.X, which is thus modified into *γ*H2A.X and sensitively marks individual DNA breaks.^[@bib3]^ Depending on the cell type, prolonged cell cycle arrest and extensive DNA damage leads to apoptosis or senescence,^[@bib4],\ [@bib5],\ [@bib6]^ but the molecular mechanism leading to either of these outcomes is not understood in detail. Recent large-scale network analyses have extended our understanding not only of genotoxic stress signaling and identified new phosphorylation but also of acetylation sites and target proteins mainly in the nucleus.^[@bib7],\ [@bib8],\ [@bib9],\ [@bib10],\ [@bib11]^ Reverse phase protein arrays (RPPA) represent a powerful technology for the sensitive detection and high-throughput quantification of protein changes at the single-cell level in a multiplex setting.^[@bib12],\ [@bib13]^ Protein arrays have already been applied to study changed expression levels or post-translational modification status of proteins in cellular stress conditions or in normal and cancerous prostate and ovarian tissue.^[@bib10],\ [@bib13],\ [@bib14],\ [@bib15]^

Depending on the cell type, IR induces different responses and proteome changes. MRC-5 primary human lung fibroblasts were used in this study as a model cell strain, because these cells tolerate IR doses up to 80 Gy and do not induce apoptosis.^[@bib16],\ [@bib17]^ Here, we applied the RPPA technology to study IR-induced stress pathways in primary cells on a 'signalosome level\' by analyzing cellular candidate markers. The RPPAs were probed with 165 different antibodies to quantify the major components and post-translational modifications of nuclear and cytoplasmic stress signaling events. Besides classical components of the DDR, such as protein level and phosphorylation changes in Chk1, p53, p21 and cyclin D1, as well as activation of the MEK-ERK, p38-Hsp27 and LKB-AMPK pathways, the RPPA analysis described here also identified specific components of the cellular IR response involved in antiapoptotic and prosurvival signaling. Among these changes was also the activation of PKC family members. The PKC signaling pathway is known to integrate extracellular signals, calcium and secondary lipid messengers (diacylglycerol, phosphatidylserine), to regulate diverse cellular responses, including apoptosis or survival during genotoxic stress.^[@bib18],\ [@bib19],\ [@bib20]^ We found that experimental inhibition or downregulation of PKC led to downregulation of prosurvival (cAMP response element-binding protein (CREB) phosphorylation) and antiapoptotic (Bad phosphorylation, Bcl-2) markers upon IR treatment and thus lead to apoptosis in normal human MRC-5 and IMR-90 fibroblasts (normal human fibroblasts (NHFs)). These results thus implicated significantly changed kinetics of prosurvival (CREB phosphorylation) and antiapoptotic (Bad phosphorylation, Bcl-2) key determinants in the ability to prevent apoptosis upon severe DNA damage. IR-induced PKC signaling is thus defined as the mechanism that prevents IR-induced apoptosis.

Results
=======

IR induces a DDR and senescence in MRC-5 fibroblasts
----------------------------------------------------

To induce DNA damage, primary human MRC-5 fibroblasts were irradiated with doses of 10 and 40 Gy. Both doses induced key components of the classical DDR, including phosphorylation of ATM at serine 1981 (pS1981), of Chk1 at serine 345 (pS345), of H2A.X at serine 139 (pS139) and stabilization of p53 protein levels ([Figure 1a](#fig1){ref-type="fig"}). The IR doses were chosen based on preliminary experiments and reflect the high capacity to repair IR-induced DNA damage of MRC-5 cells, which have been shown to efficiently remove DNA strand breaks (DSBs) up to IR doses of 80 Gy^[@bib16]^ and to enter the senescent state upon treatment with various stress stimuli.^[@bib21]^ In agreement with these findings, irradiation of MRC-5 cells with IR doses between 4 and 10 Gy induced a dose-dependent increase and time-dependent decrease of H2A.X pS139 that was mediated by ATM and DNA-PK ([Figures 1b and c](#fig1){ref-type="fig"}). The majority of DSBs was repaired within 8 h post-irradiation as indicated by the reduction of *γ*H2AX foci and the remaining *γ*H2AX foci continued to be repaired 24--48 h following IR treatment ([Supplementary Figures S1a and b](#sup1){ref-type="supplementary-material"}).

The strong reduction in colony formation of single cells after 10 days and the appearance of *β*-galactosidase-positive cells (MRC-5 and IMR-90) by 72 h after irradiation indicated growth arrest and induction of cell senescence ([Supplementary Figures S1c and d](#sup1){ref-type="supplementary-material"}), which was further supported by elevated p21 gene expression as well as p21 and p16 protein levels in MRC-5 and IMR-90 primary fibroblasts ([Supplementary Figures S1e--g](#sup1){ref-type="supplementary-material"}). Irradiation caused only a slight increase in the G2/M cell cycle population, but this effect was intensified upon ATM inhibition, suggesting that the efficient DDR prevented a more pronounced effect on cell cycle progression of irradiated MRC-5 cells ([Supplementary Figures S2a--d](#sup1){ref-type="supplementary-material"}). Cells did not exhibit elevated apoptosis even at the 8 h time point after 40 Gy irradiation, as indicated by the stable fraction of Annexin V-positive cells and undetectable expression of NOXA, PUMA and Bax (relative to a significant increase after staurosporine or cycloheximide treatment; [Supplementary Figures S3a--d](#sup1){ref-type="supplementary-material"}).

These results documented the suitability of 10 and 40 Gy IR to induce non-lethal, but senescence responses in primary fibroblasts.

IR induces significant proteome changes in MRC-5 fibroblasts
------------------------------------------------------------

To quantify the kinetic proteome changes upon IR, MRC-5 fibroblasts were harvested at the 0.5, 2, 4 and 8 h time points after IR exposure (10 and 40 Gy) and RPPA analysis was performed ([Figure 2a](#fig2){ref-type="fig"} and [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). The time points were chosen based on the observed kinetics of *γ*H2AX activation ([Figure 1b](#fig1){ref-type="fig"}) and were similar to those used in earlier studies.^[@bib7]^ The protein arrays were probed with 165 validated antibodies that specifically recognize the activation state of crucial proteins of all major signaling pathways. Only antibodies previously assessed and certified for commercial RPPA analysis services (identifying only one single band in a conventional western blot) were used and the spotted protein samples were diluted to increase the dynamic range for protein detection.^[@bib13]^ All quantitative RPPA data of three independent biological experiments (eight technical replicates) were subjected to stringent statistical analysis (ANOVA: *P*\<0.05 and fold change cutoff: fold change ≥1.5 × S.D.) ([Supplementary Figures S5--9](#sup1){ref-type="supplementary-material"}). Altogether, 90 unique proteome changes were either significant based on ANOVA and/or passed the 1.5 × S.D. cutoff ([Supplementary Figures S6 and 7](#sup1){ref-type="supplementary-material"} and Supplementary Table).

Clustering analysis identifies early cytoplasmic signals and subsequent activation of classical DDR proteins
------------------------------------------------------------------------------------------------------------

The analysis described here identified distinct clusters based on the temporal up- and downregulation of specific proteins or protein modifications. In general, treatment of MRC-5 fibroblasts with 40 Gy induced more distinct clusters as compared with 10 Gy irradiation and three broad groups were apparent ([Figures 2b and c](#fig2){ref-type="fig"} and [Supplementary Figures S10a and -b](#sup1){ref-type="supplementary-material"}). The earliest changes affected many cytoplasmic proteins such as MEK1/2 (pS217/222, pS221/226), ERK1/2 (pT202/185, pY204/187), LKB (pS428) and cyclin D1 (pT286), which were sharply induced at 0.5 h after irradiation and relaxed to much lower and constant levels thereafter (cluster 1; [Figure 2c](#fig2){ref-type="fig"} and [Supplementary Figure S10b](#sup1){ref-type="supplementary-material"}). Following this first wave of protein changes, a cluster with a distinct maximum at 2 h after 40 Gy IR appeared (clusters 2 and 5). The protein changes that appeared at later time points after 40 Gy IR comprised changes that were upregulated throughout the entire IR response or specifically increased by the higher IR dose (clusters 3 and 4). The consecutive activation and inactivation of different groups of proteins indicated a signaling cascade that progresses from the cytoplasm (early activation of MEK1/2, ERK1/2, LKB) to the nucleus (delayed activation of classical nuclear DDR proteins such as Chk1, p53, p21, MAPKAP2, Hsp27).

Validation of RPPA analysis confirms upregulation of known DDR pathways and identifies pRb downregulation
---------------------------------------------------------------------------------------------------------

The detection of many classical DDR proteome changes upon both 10 and 40 Gy IR validated the RPPA analysis of IR-treated MRC-5 fibroblasts. Known proteome changes of the DDR pathway included higher total amounts of p53 and p21 as well as increased levels of phosphorylated p38 MAPK (pT180, pY182), Hsp27 (pS78), p53 (pS15) and Chk1 (pS345) (clusters 1--3 for 10 Gy and clusters 2--5 for 40 Gy; [Figures 2b and c](#fig2){ref-type="fig"} and [Supplementary Figures S10a and -b](#sup1){ref-type="supplementary-material"}). In addition, Chk1 phosphorylation upon 10 and 40 Gy IR was confirmed by western blot analysis ([Figure 1a](#fig1){ref-type="fig"} and [Supplementary Figure S10c](#sup1){ref-type="supplementary-material"}). Levels of Chk1 phosphorylation determined by RPPA and western blot analysis showed similar kinetics (early increase after 30 min recovery from IR followed by a decline over the 8 h time course) and thus confirmed the validity of the RPPA approach. IR-induced Chk2 phosphorylation could only be shown by western blotting because of its poor antibody performance on the arrays ([Supplementary Figure S10f](#sup1){ref-type="supplementary-material"}). Even though ANOVA (*P*\<0.05) and fold cutoff (S.D.=1.5) analysis did not reveal significantly changed phosphorylation of the classical DDR marker H2A.X (pS139) in response to 10 Gy, at the 2 h time point, the Student\'s *t*-test showed a significantly increased H2A.X phosphorylation (*P*\<0.05) ([Supplementary Figures S7 and 8](#sup1){ref-type="supplementary-material"}). The kinetics of H2A.X phosphorylation upon 10 and 40 Gy correlated well, but the higher dose resulted in a stronger fold induction ([Supplementary Figures S8 and 9](#sup1){ref-type="supplementary-material"}). In agreement with previously published studies,^[@bib22]^ activation of the cytoplasmic stress kinase p38 MAPK and its downstream effector, the small heat-shock protein Hsp27, were both ATM-dependent as confirmed by western blotting and ATM inhibitor studies ([Supplementary Figure S10d](#sup1){ref-type="supplementary-material"}). Other proteome changes that were also analyzed by western blotting similarly confirmed the RPPA results, albeit western blotting revealed higher fold changes. Temporarily increased levels of p53, which is the main target for ATM in response to IR,^[@bib2]^ correlated with delayed upregulation of p21 (clusters 1 and 2 for 10 Gy; [Figure 2b](#fig2){ref-type="fig"}). Surprisingly, the important cell cycle regulator retinoblastoma protein (pRb) was significantly downregulated upon 10 Gy irradiation (cluster 5; [Figure 2b](#fig2){ref-type="fig"}), representing a proteome change that has not been implicated in the IR response previously. The RPPA-based pRb quantification correlated strongly with results obtained by western blotting ([Supplementary Figures S10e and f](#sup1){ref-type="supplementary-material"}), supporting *in vivo* pRb downregulation upon IR in MRC-5 fibroblasts. In contrast to total pRb levels, the phosphorylation of pRb at S780 (relative to total pRb) increased upon 10 Gy after 8 h and already after 2 h following irradiation with 40 Gy ([Supplementary Figure S10f](#sup1){ref-type="supplementary-material"}). In line with this finding, a strong cell-cycle effect was not observed 24--48 h after irradiation compared with a clear accumulation of cells at the G1/S boundary upon hydroxyurea treatment ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}), suggesting that the pRb changes may be important for the maintenance of cell cycle progression during the immediate IR response.

The role of the p53 pathway in DDR and its function as a 'guardian of the genome\'^[@bib23],\ [@bib24]^ is emphasized by the fact that it was significantly over-represented among the proteins responding to both 10 and 40 Gy IR ([Figure 3a](#fig3){ref-type="fig"}), and by its many interactions (more than 14 interactions) in the predicted protein network ([Figure 3b](#fig3){ref-type="fig"} and [Supplementary Figure S10g](#sup1){ref-type="supplementary-material"}). The agreement of the RPPA analysis with western blot quantifications, as well as the identification of the known key players in the DDR, confirmed the validity of the RPPA approach described here and proved that the IR-treated cells used in these experiments launched a classical DDR.

IR upregulates antiapoptotic and prosurvival markers in MRC-5 cells
-------------------------------------------------------------------

The kinetic RPPA analysis described here also revealed many new cytoplasmic factors, which were further analyzed in more detail. The here identified changes included prosurvival signals CREB (pS133) as well as MEK1/2 (pS217/222, pS221/226), ERK1/2 (pT202/185, pY204/187) and AMPK (pT172) for 40 Gy only, antiapoptotic markers (Bad pS112 and pS136, Bcl-2 pS70 for 10 Gy only) as well as a cluster comprising protein kinase C (PKC) family members. The changes in PKC family members included the phosphorylation of the novel PKC-*δ* (pT505) and of the atypical PKC*ζ/λ* (pT410/403) in the activation loop ([Figures 2b and c](#fig2){ref-type="fig"}), which marks the activated state of these two PKC isoforms.^[@bib25]^ These analyses suggested that IR treatment of primary fibroblasts activates not only the classical DDR pathways MEK-ERK and p38-Hsp27 but that also the cytoplasmic PKC signaling and specific antiapoptotic and prosurvival factors were regulated. It is thus possible that PKC signaling is involved in mediating the high IR resistance of MRC-5 and IMR-90 cells by preventing apoptosis and stimulating prosurvival factors.

Inhibitor screen identifies PKC signaling as important for IR resistance
------------------------------------------------------------------------

To elucidate whether PKC or other main signaling cascades regulate cell viability in NHFs upon IR treatment, a radiosensitivity screen with inhibitors specific for key components of the MEK-ERK, p38, JNK or PKC pathways was performed ([Figure 4](#fig4){ref-type="fig"} and [Supplementary Figures S11a--e](#sup1){ref-type="supplementary-material"}). While JNK inhibitors had only a weak effect on cell viability, inhibition of MEK and p38 affected cell proliferation, but independent of IR (i.e., similar effect in treated and untreated cells). Interestingly, already 48 h after the cotreatment with either one of two PKC inhibitors (GF109203X or Ro-318220) and with IR, MRC-5 cells showed a significant reduction in cell viability compared with cells treated with DMSO (the solvent) or with IR alone ([Figure 4](#fig4){ref-type="fig"} and [Supplementary Figure S11](#sup1){ref-type="supplementary-material"}). The NHF strain IMR-90 behaved similarly and showed a significant reduction in growth when treated with the PKC inhibitor GF109203X (2.5 *μ*M) and either 10 or 40 Gy irradiation ([Supplementary Figures S12a--c](#sup1){ref-type="supplementary-material"}). These results implicated PKC activity and signaling in the radiosensitivity of MRC-5 and IMR-90 cells.

Inhibition or downregulation of PKC directs cells towards apoptosis
-------------------------------------------------------------------

To confirm and validate PKC activation upon IR, western blot analyses were performed. In agreement with the RPPA results and the inhibitor studies, phosphorylation of PKC*ζ/λ* (pT410/pT403) as well as of PKC*β* (pT641) were confirmed to be increased upon IR ([Figures 5a and b](#fig5){ref-type="fig"}). To further characterize the mechanism of the PKC-dependent reduction in cell viability, one prosurvival (CREB phosphorylation)^[@bib26]^ and one antiapoptotic marker (phosphorylation of Bad)^[@bib27]^ was analyzed in more detail by western blotting ([Figures 5c--e](#fig5){ref-type="fig"}). In combination with IR treatment, PKC inhibition or downregulation caused strongly reduced phosphorylation of CREB (pS133) and Bad (pS136), while the total protein levels were only marginally affected ([Figures 5c and d](#fig5){ref-type="fig"} for MRC-5; [Figure 5e](#fig5){ref-type="fig"} for IMR-90). Interestingly, ATM (pS1981) was not affected by PKC inhibition ([Figures 5c and e](#fig5){ref-type="fig"}) and did not affect CREB phosphorylation or protein levels ([Figure 5c](#fig5){ref-type="fig"}), suggesting that the PKC pathway is activated independent of the classical DDR.

Although primary human fibroblasts are known to undergo senescence as a response to irradiation, the reduced phosphorylation of CREB and Bad, as well as the reduced cell viability, upon IR treatment and PKC inhibition or downregulation indicated the induction of apoptosis.^[@bib28],\ [@bib29]^ It was therefore assessed whether irradiation and PKC inhibition affects senescence and possibly induces apoptosis. Upon PKC inhibition and irradiation with 10 or 40 Gy, MRC-5 and IMR-90 cells both showed reduced *β*-galactosidase staining as compared with the DMSO-treated control, which is indicative of reduced senescence ([Figure 5f](#fig5){ref-type="fig"} and [Supplementary Figure S13a](#sup1){ref-type="supplementary-material"}). Using an alternative senescence marker, reduced p16 protein levels upon irradiation, in combination with PKC inhibition or downregulation, could be confirmed in MRC-5 cells ([Figure 5h](#fig5){ref-type="fig"}). The p16 levels were not significantly reduced in IMR-90 cells in response to IR and PKC inhibition; however; the significant reduction in p21 protein levels ([Supplementary Figures S13b and c](#sup1){ref-type="supplementary-material"}) was another alternative indicator for cellular senescence.^[@bib30]^ In contrast, in the presence of PKC inhibitors, IR treatment led to induced levels of the proapoptotic marker Bad and reduced amounts of the antiapoptotic marker Bcl-2, persistently increased p53 protein levels (in addition to the temporary p53 stabilization observed as a response to IR alone) and ARTD1 (PARP-1) cleavage (reduction in ARTD1 full-length levels and accumulation of the 89 kDa cleavage fragment), all suggestive of a switch from senescence to apoptosis, specifically upon IR in combination with PKC inhibitor treatment or PKC knockdown after 48 h of IR recovery ([Figures 5g and h](#fig5){ref-type="fig"}). Reduced ARTD1 levels and an increased sub-G1 cell population in the NHF strain IMR-90 also confirmed the findings with the MRC-5 strain ([Supplementary Figures S13b--f](#sup1){ref-type="supplementary-material"}), in addition to the reduced senescence and cell viability upon IR treatment in combination with PKC inhibition.

In summary, these results demonstrated the IR-dependent activation of cytoplasmic PKC signaling and discovered the consecutive PKC-dependent activation of prosurvival signaling mediated via CREB and Bcl-2 as well as the inactivation of proapoptotic pathways (Bad), which direct normal human MRC-5 and IMR-90 fibroblasts towards senescence and prevent IR-induced apoptosis ([Figure 6](#fig6){ref-type="fig"}). Activation of cytoplasmic PKC signaling upon IR is thus a novel mechanism that orchestrates the different IR-induced responses to ensure cell survival of primary human fibroblasts.

Discussion
==========

Human primary fibroblasts such as MRC-5 cells are able to repair DNA damage induced by IR doses up to 80 Gy.^[@bib16],\ [@bib17]^ However, it was so far not clear how MRC-5 fibroblasts prevent apoptosis, which is induced at much lower IR doses in other cell types.^[@bib31]^ Understanding the dynamics of *in vivo* signaling events in response to IR in human primary fibroblast may thus reveal medically relevant IR resistance mechanisms.

The network analysis of IR-induced proteome changes in MRC-5 fibroblasts presented here identified upregulation of known DDR factors (H2AX, p53, p21, MKK3/6, p38, MK2, Hsp27, Chk2) only 2--8 h after irradiation ([Supplementary Table](#sup1){ref-type="supplementary-material"}). In contrast, growth factor- and cytokine-dependent signaling pathways including members of the MAPK family (MEK/ERK), PKC family (PKC*δ*, PKC*ζ/λ*, PKC*β*II) as well as anti- and proapoptotic Bcl-2 family members (Bcl-2, Bad) tended to respond with faster kinetics and thus indicated that cytoplasmic signaling events are upstream of the canonical DDR. Indeed, an increasing body of evidence implicates an IR-dependent cytoplasmic signaling network in regulating DNA break repair.^[@bib32]^ Although RPPA analysis is restricted by antibody performance and reduced dynamic range, western blotting confirmed the tested proteome changes discovered by RPPA analysis, supporting the stringent statistical analysis. However, western blotting indicated that RPPA analysis usually underestimated the IR-induced proteome changes.

Most proteome changes, in particular upon 40 Gy IR, affected mitogenic signaling events controlling cell survival (MKK3/6-p38-MK2 pathway, MEK-ERK pathway, LKB-AMPK pathway, PKC-Bad pathway). Previously published results have demonstrated p38-MK2 pathway activation and subsequent cell cycle arrest in G2/M in response to UV irradiation, thus protecting DNA damaged cell from entering mitosis, which would lead to a mitotic catastrophe and eventually to apoptosis.^[@bib33],\ [@bib34]^ In agreement with these findings, in response to 10 and even more pronounced upon 40 Gy, we could show activation of the major p38-MK2 pathway components, with phosphorylation of MKK3/6, p38, MAPKAP-2 (MK2) and Hsp27, besides the slight increase in the percentage of the G2/M cell cycle population 24--48 h after IR recovery ([Supplementary Figures S2 and S7](#sup1){ref-type="supplementary-material"}).

The most important finding of this systematic RPPA analysis is the identification of PKC as a key player that orchestrates the downstream signaling pathways regulating apoptosis and cell survival ([Figure 6](#fig6){ref-type="fig"}). IR-dependent PKC activation regulated Bad, Bcl-2 and CREB to prevent apoptosis and to induce prosurvival signaling. Whether PKC family members directly phosphorylate the identified downstream proteins or rather indirectly affect their activation is currently not known. Interestingly, PKCs are known to translocate to the nucleus^[@bib35]^ and all identified regulatory components (Bad, Bcl-2, CREB) contain putative target sites for phosphorylation by PKC.^[@bib36]^ PKC inhibitors, or PKC downregulation before IR treatment, downregulated antiapoptotic factors (Bad phosphorylation, Bcl-2) and induced apoptosis (ARTD1 cleavage, increased p53 stabilization, Bad upregulation, increased sub-G1 population and decline in cell number). Sensitization of primary fibroblasts by PKC inhibitors or downregulation thus induced an apoptotic program that is mediated by effects on CREB, Bad and proapoptotic genes. PKC-dependent regulation of cell survival, apoptosis as well as cell cycle progression is thus proposed as a part of the mechanism by which primary fibroblasts resist high IR doses and circumvent apoptosis, which is in agreement with the high DNA repair efficiency and the PKC-dependent regulation of p53 function.^[@bib16],\ [@bib37]^ The inhibitor and siRNA experiments described here imply PKC signaling in the prevention of apoptosis in human primary MRC-5 and IMR-90 fibroblasts. However, these analyses do not identify which PKC family member mediates the observed phenotypes. The RPPA analysis identified PKC*δ* activation, which was previously shown to be induced upon DNA damage^[@bib38]^ and linked to pro- and antiapoptotic functions (Basu and Pal^[@bib39]^ and many reference therein). Future studies on the upstream regulators relevant for PKC activation upon IR in MRC-5 and IMR-90 cells will identify the required cofactors and signaling components and thereby indicate which PKC subgroup mediates the antiapoptotic function. Taken together, our findings provide the cellular mechanism, which is responsible for this phenotype and may thus open up possiblities for new treatment schemes of highly IR-resistant tumors.

This result has not only important implications for our understanding of the IR response but also for the comprehension of nuclear regulatory events and supports the concept of the cellular, in contrast to the nuclear, radiation response.^[@bib40]^ Cellular stress such as IR is perceived at the plasma membrane and in the cytoplasm and initiates cytoplasmic signaling pathways that consecutively control nuclear events such as DNA repair. This is also suggested by the induction of IR-induced signaling in cells exposed to IR conditioned medium, which is termed the 'bystander effect\'.^[@bib41]^ The classical DDR, comprised of nuclear events regulating cell cycle progression and DNA repair, is thus preceded and controlled by the cytoplasmic radiation response, which is mediated by the PKC signaling pathway as well as other signaling pathways such as the MEK-ERK pathway.

This RPPA network analysis of IR-induced signaling identified a new, cytoplasmic, PKC-dependent regulatory mechanism that conditions stressed cells by preventing apoptosis. The PKC-dependent induction of prosurvival signaling and evasion of apoptosis is thus a mechanism, which renders primary human fibroblasts resistant to high doses of IR, and may thereby protect the microenvironment and permit survival of tumors. Our results thus provide an explanation for the cellular response to severe irradiation stress and will therefore help optimize and improve radiotherapy.

Materials and Methods
=====================

Cell culture, IR treatment, siRNA transfection, lysis, viability and senescence assays
--------------------------------------------------------------------------------------

The MRC-5 and IMR-90 human lung fibroblast cell strains^[@bib42],\ [@bib43]^ were obtained from the American Type Culture Collection and cultured in supplemented MEM (Invitrogen; Life Technologies, Carlsbad, CA, USA). Cells were exposed to IR using an X-ray generator (Pantak Seifert X-ray System, Ahrensburg, Germany; 120 kV; 19 mA; aluminum filter, 3.11 Gy/min) and recovered for different time periods. Inhibitor treatment was performed as indicated in the figure legends before the exposure to IR. To reduce PKC expression, 1 × 10^5^ MRC-5 cells were transfected using human siPKC pan (Santa Cruz Biotechnology, Dallas, TX, USA; sc-29449) over 3 and 4 days, before irradiation. Whole cell extracts were prepared with Zeptosens Cell Lysis Buffer CLB1 (Bayer Technology Services GmbH, Leverkusen, Germany) or RIPA lysis buffer and total protein concentration was determined using the standard Lowry method. Cell viability was determined by seeding 2 × 10^3^ cells in 96-well plates overnight before irradiation or drug treatment. Cell viability was quantified using the WST-1 proliferation reagent (Roche, Basel, Switzerland) or alamarBlue cell viability assay (Invitrogen) and a plate reader (Tecan, Männedorf, Switzerland). The clonogenic and senescence assays were performed as described elsewhere.^[@bib44],\ [@bib45]^

Reverse phase protein arrays
----------------------------

RPPA were prepared as described.^[@bib46]^ In brief, whole cell extracts were spotted onto hydrophobically coated Zeptosens Chips (Bayer Technology Services GmbH). Serially diluted lysates (100, 75, 50 and 25%) were arrayed in duplicates onto hydrophobic Zeptosens Chips using the Nanoplotter NP2.0 (GeSiM; Gesellschaft für Silizium-Mikrosysteme mbH, Grosserkmannsdorf, Germany), followed by blocking in an ultrasonic nebulizer (ZeptoFOG; Bayer Technology Services GmbH). Antibody incubation, microarray data acquisition (ZeptoREADER; Bayer Technology Services GmbH) and data analysis (ZeptoVIEW version 3.1.0.2; Bayer Technology Services GmbH) was performed exactly as described.^[@bib47]^ The eight data points (100, 75, 50 and 25% lysate amount in duplicates) were fitted using a weighted linear least-squares fit^[@bib48]^ and the relative fluorescence intensity determined by interpolating at the median protein concentration or modification. To correct for small variations in protein content, relative intensities were normalized to the signals of *β*-catenin, which did not show any significant variation (ANOVA, *P*\<0.05; 1.5 × S.D.) in response to IR over indicated time points.

Significance and clustering analysis
------------------------------------

To identify significant proteome changes in response to IR, relative fluorescence intensities were imported to MeV version 4.6.^[@bib49]^ Relative fluorescence intensities were log 2 transformed and normalized, before performing statistical analysis using one-way ANOVA as described in Zar.^[@bib50]^ The mean transformed fluorescence intensities for group 1 (untreated: 0.5, 2, 4 and 8 h), group 2 (biological triplicates of 10 or 40 Gy at 0.5 h), group 3 (biological triplicates of 10 or 40 Gy at 2 h), group 4 (biological triplicates of 10 or 40 Gy at 4 h) and group 5 (biological triplicates of 10 or 40 Gy at 8 h) were compared using F-statistics with *P*\<0.05. Owing to technical problems during preparation of the serial dilution of the whole cell extracts, two biological replicates for the 8 h time point of 10 Gy irradiated samples (10 Gy at 8 h) and one biological replicate for the 2 and 8 h time point of 40 Gy irradiated samples (40 Gy at 2 h and 40 Gy at 8 h) were excluded from the statistical analysis. For fold-change analysis, transformed means of the biological replicates were normalized to the untreated sample (set as 1) and proteome changes were filtered (cutoff set at 1.5 × S.D. equal to log 2\>0.27/\<−0.27 for 10 Gy or log 2\>0.29/\<−0.29 for 40 Gy). Significant proteome changes in response to IR were selected, if significant by one-way ANOVA (*P*\<0.05) and fold cutoff (1.5 × S.D.). Alternatively, significance analysis was performed using two-tailed Student\'s *t*-test (*P*\<0.05). Similar profiles of the fold changes over time were identified by clustering analysis using the Self Organizing Tree Algorithm^[@bib51]^ and default parameters of MeV version 4.6.^[@bib49]^

Pathway and network analysis
----------------------------

Gene pathway membership data were obtained from protein interaction database, PID^[@bib52]^ and KEGG.^[@bib53]^ A total of 200 and 211 pathways were obtained from PID and KEGG, respectively. For statistical analysis, all analyzed proteins in this study (unique IDs) were set as the background list and all pathways consisting of more than five proteins from the background list were considered for statistical analysis by Fisher\'s exact test, resulting in a total of 93 pathways from PID and 63 from KEGG. Fisher\'s exact test was performed to identify pathways significantly affected by proteins (modifications) altered in response to irradiation (significant by ANOVA and fold change) using the R statistical framework.^[@bib54]^ To account for multiple testing, *P*-values were corrected for false discovery rates (FDRs) using Benjamini--Hochberg correction. We have used an FDR-corrected *P-*value cutoff of 0.1 to identify pathways significantly affected by proteome changes.

Significant proteome changes, identified by statistical (ANOVA) and fold-change analysis (log 2 cutoff) were subjected to protein--protein interaction analysis using STRING (v. 9.0, <http://www.string-db.org/>).^[@bib55]^ Only interactions with a STRING score of 0.7 and above were further analyzed using Cytoscape (<http://www.cytoscape.org/>).^[@bib56]^

Immunoblotting
--------------

For western blot analysis, proteins were separated by SDS-PAGE gel electrophoresis and bands were visualized by using either horseradish peroxidase-conjugated antibodies (1 : 5000; GE Healthcare, Life Sciences, Uppsala, Sweden) and ECL detection (GE Healthcare) or IR-dye-conjugated antibodies (1 : 15 000; LI-COR Biosciences) and detection by the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE, USA). For quantification, bands were analyzed by ImageJ 1.46 (ref. [@bib57]) and the Odyssey imaging software (LI-COR Biosciences).

Antibodies used for western blotting were anti-ATM (GeneTex, Irvine, CA, USA), anti-ATM Phospho (pS1981) (Epitomics-an Abcam Company, Burlingame, CA, USA), anti-Bad (CST), anti-Bad Phospho (pS136) (Cell Signaling Technology (CST), Danvers, MA, USA), anti-Chk1 (CST), anti-Chk1 Phospho (pS345) (1 : 500; CST), anti-Chk2 Phospho (pT68) (CST), anti-CREB (CST), anti-CREB Phospho (pS133)/anti-ATF-1 (phospho) (CST), anti-histone H2A.X Phospho (pS139) (Millipore, Billerica, MA, USA), anti-Hsp27 (CST), anti-Hsp27 Phospho (pS78) (1 : 500; CST), anti-PARP1 (Santa Cruz Biotechnology), anti-PARP1 cleaved (1 : 500; CST), anti-p16 (1 : 500; Santa Cruz Biotechnology), anti-p21 (Santa Cruz Biotechnology), anti-p38 (CST), anti-p38 Phospho (pThr180/Tyr182), anti-p44/42 Erk1/2 (CST), anti-p44/42 Erk1/2 Phospho (pThr202/Tyr204) (CST), anti-p53 (Santa Cruz Biotechnology), anti-Rb (1 : 500; Epitomics), anti-Rb (pS780) (CST), anti-tubulin (1 : 10 000; Sigma-Aldrich, St Louis, MO, USA), anti-PKC*β*II Phospho (pT641) (CST), anti-PKC*δ* (CST), anti-PKC*ζ/λ* (CST) and anti-PKC*ζ/λ* Phospho (pT410/pT403) (CST). Unless otherwise stated, antibody dilution was 1 : 1000.

Immunofluorescence microscopy
-----------------------------

MRC-5 cells grown on cover slips over night (≈1 × 10^4^ cells) were irradiated and immunohistochemically stained with primary (1 : 500 mouse anti-histone H2A.X Phospho (S139) immunoglobulin G1 (IgG1) (Millipore) or 1 : 500 rabbit anti-53BP1 IgG1 (Santa Cruz Biotechnology)) and secondary antibodies (1 : 250 FITC- or cyanine 3-conjugated IgG anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) or 1 : 250 Alexa Fluor 488-conjugated anti-rabbit IgG (Invitrogen)).

Flow cytometry
--------------

Cell cycle analysis of IR-treated or -untreated MRC-5 cells was performed using standard ethanol fixation/PI-staining protocol and flow cytometry analysis (FACS) with a Dako CyAn ADP flow cytometer (Dako, North America, Carpinteria, CA, USA). For sub-G1 peak analysis of IMR-90, cell debris and necrotic cells were gated out according to the protocol of Riccardi and Nicoletti.^[@bib58]^ Annexin V staining was performed using the FITC Annexin V apoptosis detection kit (BD Biosciences, San Jose, CA, USA) and a Dako CyAn ADP flow cytometer (Dako).

RNA extraction and real-time PCR analysis
-----------------------------------------

Total RNA was reverse transcribed using High-Capacity cDNA Reverse Transcription kit (Applied Biosystems; Life Technologies). Real-time PCR was performed using SYBR green premixed buffer and analyzed by the Rotor-Gene Q cycler (Qiagen, Hilden, Germany).
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![Induction of the DRR and efficient repair of IR-induced DNA breaks over 48 h in NHFs. (**a**) Western blot analysis of irradiated MRC-5 cells after recovery from IR for 0.5--8 h. (**b**) Immunofluorescence staining of MRC-5 cells irradiated with X-ray doses of 1--10 Gy or left untreated (U) and recovered for 15 min--8 h. (**c**) MRC-5 cells were pretreated with 10 *μ*M KU-55933 (ATMi) and/or 10 *μ*M Nu7441 (DNA-PKi) before irradiation with 6 Gy, or left untreated (U) as a control. Cells were stained with anti-*γ*H2A.X (phospho-Ser139) 1 h post-irradiation. ATM, Ataxia-telangiectasia mutated; Chk, checkpoint kinase; DAPI, 4′,6-diamidino-2-phenylindole; DNA-PK, DNA protein kinase; DMSO, dimethyl sulfoxide](cddis201315f1){#fig1}

![Identification of significant proteome changes in response to IR. (**a**) Workflow for the characterization of IR-induced proteome changes by RPPA. MRC-5 cells were left untreated (U) or irradiated in biological triplicates with 10 or 40 Gy. At different time points, cell lysates were prepared and spotted in equal amounts on hydrophobic glass slides. Each array was incubated with a different primary antibody, directed against a protein of interest and a secondary fluorophore-labeled antibody. Relative fluorescence intensities were quantified and used for statistical data analysis to identify significant proteome changes in response to irradiation. (**b** and **c**) Time-profile clustering of IR-dependent proteome changes (analysis of variance (ANOVA), *P*\<0.05; 1.5 S.D. cutoff) using Self-Organizing Tree Algorithm (SOTA) showing protein expression and modification (e.g., phosphorylation) in green or downregulation and de-modification (e.g., de-phosphorylation) in red. (**b**) Clustering of proteome changes upon irradiation with 10 Gy. (**c**) Clustering analysis of IR-dependent proteome changes upon 40 Gy treatment. AMPK, AMP-activated protein kinase; Bad, Bcl2 antagonist of cell death; EGFR, epidermal growth factor receptor; elF4E, Eukaryotic initiation factor elF4E like protein; ERK, extracellular signal-regulated kinase; Hsp, heat-shock protein; JNK, c-Jun NH2-terminal kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; PAK, p21-activated kinase; PKA RII, cAMP-dependent protein kinase type II regulatory subunit; PKC, protein kinase C; Rb, Retinoblastoma-associated protein; SAPK, stress-activated protein kinase; SMAD, Homolog of mothers against decapentaplegic homolog from *Drosophila* and SMA from *Caenorhabditis elegans*; Stat6, signal transducer and activator of transcription 6](cddis201315f2){#fig2}

![Pathway and protein--protein interaction analysis of significant IR-induced proteome changes. (**a**) Enrichment of pathways from the pathway interaction database (PID) with significant proteome changes (analysis of variance (ANOVA), *P*\<0.05; 1.5 S.D.) induced by 10 Gy only (red), 40 Gy only (blue) and overlapping changes (green) using Fisher\'s exact test. (FDR-corrected *P*-value cutoff=0.1). (**b**) Protein--protein interaction analysis of significant proteome changes induced by 40 Gy using STRING, with a STRING score cutoff \>0.7. Colors indicate phosphorylation (light blue), total protein changes (violet), phosphorylation and total protein changes (orange). Circles represent unique changes and squares overlapping changes. Large symbols indicate proteins that interact with more than 14 members. BAD, Bcl2 antagonist of cell death; CCND, Cyclin D; CDC42, Cell division control protein 42 homolog; CDKN1A, Cyclin-dependent kinase inhibitor 1A (p21); CHEK1, Checkpoint kinase-1; CXCR3, C-X-C chemokine receptor type 3; EGFR, Epidermal growth factor receptor; EPHB, Ephrin type-B receptor; ErbB, Epidermal growth factor receptor; HSPB, Heat shock protein beta; MAP2K1, Dual specificity mitogen-activated protein kinase kinase 1 (MEK1); MAP2K2, Dual specificity mitogen-activated protein kinase kinase 2 (MEK2); MAP2K3, Dual specificity mitogen-activated protein kinase kinase 3 (MKK3); MAP2K6, Dual specificity mitogen-activated protein kinase kinase 6 (MKK6); MAPK, mitogen-activated protein kinase; MAPK1, Mitogen-activated protein kinase 1 (ERK-2); MAPK3, Mitogen-activated protein kinase 3 (ERK-1); MAPKAP2, MAP kinase-activated protein kinase 2 (MK2); PAK, p21-activated kinase; PRKAA1, 5\'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK1); PRKCD, protien kinase C delta type; PRKCZ, Protein kinase C zeta type; PRL, prolactin; SRC, Proto-oncogene tyrosine-protein kinase Src; STK11, Serine/threonine-protein kinase STK11 (LKB1); Trk, tropomyosin-receptor-kinase.](cddis201315f3){#fig3}

![PKC inhibition sensitizes MRC-5 to 10 and 40 Gy after 48 h. Cell viability assay (WST-1) of MRC-5, pretreated with p38 (SB203580, 10 *μ*M), MEK (PD98059, 20 *μ*M) or PKC inhibitor (GF109203X, 10 *μ*M) and as a positive control for cell death with doxorubicin (Dox, 1 *μ*g/ml) for 2 h before IR and recovery for the indicated time points (*n*=3). DMSO, dimethyl sulfoxide; MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; NS, nonsignificant; PKC, protein kinase C; U, untreated; \**p*\<0.05; \*\**p*\<0.01; \*\*\**p*\<0.001](cddis201315f4){#fig4}

![Inhibition or downregulation of PKC reduces prosurvival signaling in NHFs. Phosphorylation of PKC*ζ/λ* and Bad (**a**) or PKC*β*II and ERK (**b**) in response to IR. Western blot analysis of irradiated MRC-5 cells after recovery for 0.5--2 or 2--4 h following IR. Total PKC*ζ/λ* and Bad (**a**) or total PKC*δ* and ERK (**b**) were used as loading control. (**c**) Phosphorylation of CREB and ATF-1 is downstream of PKC activation in response to IR. Western blot analysis of irradiated MRC-5 cells (4 h recovery) that were treated either with the PKC-specific inhibitor Ro-318220 (5 *μ*M, added before irradiation) or with the ATM inhibitor KU-55933 (10 *μ*M, added before irradiation). Tubulin was used as loading control. (**d**) Phosphorylation of Bad is downstream of PKC activation in response to IR. Western blot analysis of irradiated MRC-5 cells (4 h recovery) that were exposed to the PKC-specific inhibitor GF109203X (5 *μ*M, for 2 h) or siPKC pan. (**e**) Phosphorylation of CREB, ATF-1 and Bad is downstream of PKC activation in response to IR. Western blot analysis of irradiated IMR-90 cells (4 h recovery) that were treated with GF109203X or Ro-318220 (2.5 *μ*M, 2 h pre-incubation before irradiation). Tubulin was used as loading control. (**f**) Pharmacological inhibition of PKC reduces senescence associated *β*-galactosidase (*β*-gal) staining. SA-*β*-gal staining of irradiated MRC-5 in presence of PKC inhibitor (GF109203X, 5 *μ*M, 72 h recovery) with untreated (U) as control. (**g**) Pharmacological inhibition of PKC (GF109203X, 5 *μ*M) leads to ARTD1 cleavage, Bcl-2 downregulation and Bad upregulation 48 h after IR. (**h**) Knockdown of PKC leads to increased p53 stabilization and reduced p16 protein levels as well as increased ARTD1 cleavage in response to 10 and 40 Gy at 48 h after IR. Western blot analysis of irradiated MRC-5, transfected either with siPKC pan or scrambled siRNA as control for 3 days before IR. Tubulin was used as loading control. ARTD1, ADP-ribosyltransferase diphtheria toxin-like 1; ATF, cyclic AMP-dependent transcription factor 1; ATM, ataxia--telangiectasia mutated; Bad, Bcl2 antagonist of cell death; Bcl-2, B-cell lymphoma 2; CREB, cAMP response element-binding protein; DMSO, dimethyl sulfoxide; ERK, extracellular signal-regulated kinase; Et, etoposide; PKC, protein kinase C](cddis201315f5){#fig5}

![Model of PKC-dependent cellular prosurvival signaling in response to IR. IR-induced PKC signaling orchestrates cell survival via upregulation of Bcl-2 and phosphorylation of Bad and CREB. Hypersensitization with PKC inhibitors (GF109203X, Ro-318220) and genetic knock down (siPKC pan) leads to IR-induced activation of apoptosis mediated by p53 stabilization, upregulation of Bad and ARTD1 cleavage, as well as reduced senescence mediated via decrease in p21 protein levels and reduced *β*-galactosidase (*β*-Gal) activity in response to IR. ARTD1, ADP-ribosyltransferase diphtheria toxin-like 1; Bad, Bcl2 antagonist of cell death; Bcl-2, B-cell lymphoma 2; CREB, cAMP response element-binding protein](cddis201315f6){#fig6}
